DISCUSSION AND ANALYSIS FOR PERIOD ENDED 30 SEPTEMBER 2017 3. Financial highlights (based on Thai FRS) Q3 2017 Financial Position Summary as of 30 September 2017 compared to Q3 2016: Q3 2017 Q3 2016 YoY change
จดหมายชี้แจงปี60e February 22, 2018 The Managing Director The Stock Exchange of Thailand Subject : Management Discussion and Analysis Ending 31 December 2017 Summary of operating result between 2017
comparing to 2018 or 11.9% mostly due to soften Ethylene and Glycerin price from ample supply and lower crude oil price. Summary of Performance For Q1 2019, the Company and its subsidiaries recorded net
MAY 14,2019 Dear Director and The Manager of SET Re: Operating Performance’s Summary of Q1/2019 In the first quarter of 2019, the Company has sales amount equivalent to 295.49 million baht. It
MTHB according to the change of severance payment policy following the amended Labor Protection Act. * Note Please find further information in the consolidated financial statements. 2 Summary of
impairment loss from the liquidation of Solvay Biochemicals (Taixing) Limited (“SBT”) were fully booked in 2017. * Note Please find further information in the consolidated financial statements. 2 Summary of
interest from 28.49% to 20.56% as a consequence of newly issued ordinary shares of Pimai Salt Company Limited. * Note Please find further information in the consolidated financial statements. 2 Summary of
November 13,2019 Dear Director and The Manager of SET Re: Operating Performance’s Summary of Q3/2019 During the third quarter of 2019, total sales amount of the Company was 27 6.71 million baht. It
the consolidated financial statements. 2 Summary of Performance For Q3 2019, the Company and its subsidiaries recorded net profit of 1,070 MTHB, increased by 445 MTHB or 71.2% comparing to Q3 2018. This
mostly due to unrealized loss on exchange rate. Summary of Performance For Q1 2020, the Company and its subsidiaries recorded net profit of 780 MTHB, increased by 232 MTHB or 42% comparing to Q1 2019. This